obesity drug news today glp-1 2025 Dozens of new drugs are coming: these are the ones to watch GLP-1 Agonists Weight Loss Drugs

For example, triple-target agonists like retatrutide are leading multi-target GLP-1 drugs

That last part is key: slowed gastric emptying is part of how these medications make you feel fuller longer

Glucagon-like peptide-1 receptor signaling in the ventral tegmental area reduces alcohol self-administration in male rats

Potential for personalized obesity therapies using AI-driven patient profiling and biomarker analysis

I do notice that my face is slimmer, which is likely due to the inflammation

Stopping GLP-1 therapy in diabetic patients risks not only weight regain but also deterioration of blood sugar control, potentially requiring additional diabetes medications